– CANADA, Vancouver – Telecure Technologies Inc. (CSE: TELE | FSE: 6MZ) a U.S.-focused health IT company which develops technology to make healthcare more accessible and efficient, today announced the appointment of CFO Eli Dusenbury to the Board of Directors, with immediate effect.
“Mr. Dusenbury has been instrumental to Telecure’s success. As Telecure grows I believe Eli will continue to be an invaluable asset with his extensive experience in financial reporting and acquisitions. I look forward to working with Mr. Dusenbury as a Board member as we continue to build a strong foundation for the future of Telecure.” said Board Chairman, Josh Rosenberg.
About Eli Dusenbury
Mr. Dusenbury, CPA, CA has experience in public accounting, providing services to both public and private sector clients reporting in Canada and the United States across a broad range of industries including healthcare, technology, agriculture, engineering, mining & exploration, manufacturing, and financing. Mr. Dusenbury obtained his Chartered Professional Accountant designation in 2011.
Mr. Dusenbury has served as a consultant for audit and public practice firms in both Canada and the United States and has held Directorships and CFO positions for multiple international public and private entities.
About Telecure Technologies Inc.
Telecure is a U.S. focused health IT company that specializes in using technology to make healthcare more accessible and efficient. Telecure offers customized solutions for telemedicine needs. Through an acquisition strategy and unique customization capabilities, Telecure is focused on advancing its patient and user base. The Company provides a complete telemedicine solution via its platforms CallingDrT and FindingDr.
For more information: https://telecure.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
